Effects of Zolmitriptan (ZomigTM) on Central Serotonergic Neurotransmission as Assessed by Active Oddball Auditory Event-Related Potentials in Volunteers without Migraine

Item

http://www.wikidata.org/entity/Q59305050

description

article

@en

im März 1999 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в березні 1999

@uk

name

Effects of Zolmitriptan (Zomig ...... in Volunteers without Migraine

@en

Effects of Zolmitriptan

@nl

type

Item

label

Effects of Zolmitriptan (Zomig ...... in Volunteers without Migraine

@en

Effects of Zolmitriptan

@nl

prefLabel

Effects of Zolmitriptan (Zomig ...... in Volunteers without Migraine

@en

Effects of Zolmitriptan

@nl

P1476

Effects of zolmitriptan (Zomig ...... in volunteers without migraine

@en

P2093

A Dane

http://www.w3.org/2001/XMLSchema#string

J Kemp

http://www.w3.org/2001/XMLSchema#string

L Cummings

http://www.w3.org/2001/XMLSchema#string

R A Yates

http://www.w3.org/2001/XMLSchema#string

R Dixon

http://www.w3.org/2001/XMLSchema#string

P2860

Regulation of serotonin release in the frontal cortex and ventral hippocampus of homozygous mice lacking 5-HT1B receptors: in vivo microdialysis studies

Intensity dependence of auditory evoked potentials is pronounced in migraine: an indication of cortical potentiation and low serotonergic neurotransmission?

Preclinical studies on the anti-migraine drug, sumatriptan.

Joint 1994 Wolff Award Presentation. Peripheral and central trigeminovascular activation in cat is blocked by the serotonin (5HT)-1D receptor agonist 311C90.

Structure and function of the brain serotonin system.

Optimizing the dose of zolmitriptan (Zomig, 311C90) for the acute treatment of migraine. A multicenter, double-blind, placebo-controlled, dose range-finding study. The 017 Clinical Trial Study Group.

Intensity dependence of auditory evoked potentials as an indicator of central serotonergic neurotransmission: a new hypothesis.

Pre-clinical pharmacology of zolmitriptan (Zomig; formerly 311C90), a centrally and peripherally acting 5HT1B/1D agonist for migraine.

Intensity dependence of the cortical auditory evoked potentials as a surrogate marker of central nervous system serotonin transmission in man: demonstration of a central effect for the 5HT1B/1D agonist zolmitriptan (311C90, Zomig).

Measuring central action of acute antimigraine drugs in humans.

P304

100-6; discussion 73

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1046/J.1468-2982.1999.019002100.X

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Andrew Hughes

P577

1999-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10214535

http://www.w3.org/2001/XMLSchema#string

P921

migraine disorder